Phathom Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$201,592,000 and profit margin reached -29559%. Total operating expenses were $167,827,000.
Profit Margin
| 2018 | 0 | -1.28M | |
|---|---|---|---|
| 2019 | 0 | -209.74M | |
| 2020 | 0 | -133.31M | |
| 2021 | 0 | -148.09M | |
| 2022 | 0 | -223.00M | |
| 2023 | 682K | -201.59M | -29558.94% |
PHAT Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 682K | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 167K | 620K | 521K | 300K | 8K | 0 |
Gross profit | 515K | -620K | -521K | -300K | -8K | 0 |
Operating exp. | ||||||
Research and development | 49.89M | 71.44M | 72.33M | 98.14M | 99.27M | 20K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 167.82M | 172.44M | 135.08M | 125.66M | 106.21M | 1.22M |
Operating income | -167.31M | -172.44M | -135.08M | -125.66M | -106.21M | -1.22M |
Other income (expenses), net | -34.28M | -25.28M | -8.80M | -3.40M | -148.91M | -50K |
Income before tax | -201.59M | -197.72M | -143.88M | -129.06M | -255.13M | -1.28M |
Income tax expense | 0 | 25.28M | 4.21M | 4.25M | -45.38M | 13K |
Net income | -201.59M | -223.00M | -148.09M | -133.31M | -209.74M | -1.28M |
Earnings per share | ||||||
Basic EPS | -3.93 | -5.7 | -4 | -4.01 | -8.48 | -0.15 |
Diluted EPS | -3.93 | -5.7 | -4 | -4.01 | -8.48 | -0.15 |
| Data source | Data source | Data source | Data source | Data source |